Does Rallies show Form 4 insider transactions for BHVN?

Yes. Rallies tracks BHVN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BHVN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BHVN. It does not provide personalized investment advice.

BHVN (Biohaven Ltd.) Stock Analysis - Insider Trades

Biohaven Ltd. (BHVN) is a publicly traded Healthcare sector company. As of May 21, 2026, BHVN trades at $9.10 with a market cap of $1.28B and a P/E ratio of -0.60. BHVN moved +5.66% today. Year to date, BHVN is -10.88%; over the trailing twelve months it is -45.54%. Its 52-week range spans $7.48 to $55.70. Analyst consensus is buy with an average price target of $19.60. Rallies surfaces BHVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BHVN stock inside the company?

Recent BHVN insider activity includes Clark George C. bought 17.00K, Bailey Gregory bought 400.00K, CHILDS JOHN W bought 3.33M, Coric Vlad bought 333.33K, and Coric Vlad bought 333.33K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BHVN Key Metrics

Key financial metrics for BHVN
Metric	Value
Price	$9.10
Market Cap	$1.28B
P/E Ratio	-0.60
EPS	$-14.83
Dividend Yield	0.00%
52-Week High	$55.70
52-Week Low	$7.48
Volume	58
Avg Volume	0
Revenue (TTM)	$859.68M
Net Income	$-930.69M
Gross Margin	85.63%

Recent BHVN Insider Trades

Clark George C. bought 17.00K (~$144.77K) on Nov 17, 2025.
Bailey Gregory bought 400.00K (~$3.00M) on Nov 13, 2025.
CHILDS JOHN W bought 3.33M (~$25.00M) on Nov 13, 2025.
Coric Vlad bought 333.33K (~$2.50M) on Nov 13, 2025.
Coric Vlad bought 333.33K (~$2.50M) on Nov 13, 2025.

Latest BHVN News

Biohaven Prepares Mid-2026 Pivotal IgAN, Graves' Trials with $351.8M Cash — May 4, 2026
Biohaven Completes Enrollment in Phase 2 Obesity Trial; Data Due 2H 2026 — Mar 19, 2026
Xenon’s 42.7% Seizure Reduction Spurs Biohaven Premarket Rally — Mar 9, 2026
Biohaven Price Target Rises to $23, BTIG Establishes $24 Forecast — Mar 2, 2026

BHVN Analyst Consensus

12 analysts cover BHVN: 0 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.60.

Common questions about BHVN

Who is trading BHVN stock inside the company?: Recent BHVN insider activity includes Clark George C. bought 17.00K, Bailey Gregory bought 400.00K, CHILDS JOHN W bought 3.33M, Coric Vlad bought 333.33K, and Coric Vlad bought 333.33K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BHVN?: Yes. Rallies tracks BHVN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BHVN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BHVN. It does not provide personalized investment advice.